STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
RAC1 |
IPI00219675 |
1.167 |
Evidence |
|
STAT3 |
|
EP300 |
IPI00478752 |
1.167 |
Evidence |
|
CAT |
CAT: Catalase |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
1.16 |
Evidence |
O
|
ITGB4BP |
ITGB4BP, EIF3A, OK/SW-cl.27, EIF6: Eukaryotic translation initiation factor 6 |
MKI67IP |
MKI67IP, NIFK, NOPP34: MKI67 FHA domain-interacting nucleolar phosphoprotein |
1.155 |
Evidence |
O
|
ITGB4BP |
ITGB4BP, EIF3A, OK/SW-cl.27, EIF6: Eukaryotic translation initiation factor 6 |
PAK1IP1 |
PAK1IP1, PIP1, WDR84: p21-activated protein kinase-interacting protein 1 |
1.155 |
Evidence |
O
|
ITGB4BP |
ITGB4BP, EIF3A, OK/SW-cl.27, EIF6: Eukaryotic translation initiation factor 6 |
NOC2L |
NOC2L: Nucleolar complex protein 2 homolog |
1.155 |
Evidence |
O
|
RPLP0 |
RPLP0: 60S acidic ribosomal protein P0 |
ITGB4BP |
ITGB4BP, EIF3A, OK/SW-cl.27, EIF6: Eukaryotic translation initiation factor 6 |
1.155 |
Evidence |
O
|
CCNH |
CCNH: Cyclin-H |
ITGB4BP |
ITGB4BP, EIF3A, OK/SW-cl.27, EIF6: Eukaryotic translation initiation factor 6 |
1.155 |
Evidence |
O
|
HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
HTATIP |
IPI00394657 |
1.155 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
PRKCB1 |
IPI00219628 |
1.155 |
Evidence |
|
EPN2 |
IPI00397382 |
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
1.155 |
Evidence |
|
EIF2B2 |
EIF2B2, EIF2BB: Translation initiation factor eIF-2B subunit beta |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
1.147 |
Evidence |
O
|
RANBP5 |
|
RPL23A |
RPL23A: 60S ribosomal protein L23a |
1.147 |
Evidence |
|
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
1.142 |
Evidence |
|
ACTA1 |
ACTA1, ACTA: Actin, alpha skeletal muscle |
DTNA |
DTNA, DRP3: Dystrobrevin alpha |
1.137 |
Evidence |
|
ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
ARPC2 |
ARPC2, ARC34, PRO2446: Actin-related protein 2/3 complex subunit 2 |
1.135 |
Evidence |
O
|
ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
1.135 |
Evidence |
O
|
EDA |
IPI00023765 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
IL4 |
IL4: Interleukin-4 precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
1.132 |
Evidence |
|
MAPK10 |
MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
1.132 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
DRD2 |
DRD2: D(2) dopamine receptor |
1.132 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|